During the past decade, USC Norris Oncology/Hematology-Newport Beach conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 16 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 15 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "USC Norris Oncology/Hematology-Newport Beach" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "University of Southern California" with 7 trials sponsored and "NRG Oncology" with 7 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "USC Norris Oncology/Hematology-Newport Beach" #1 collaborator was "National Cancer Institute (NCI)" with 33 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Biologics, Inc." with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "USC Norris Oncology/Hematology-Newport Beach" are "Invasive Breast Carcinoma" (4 trials), "Malignant Solid Neoplasm" (3 trials), "Stage IV Bladder Cancer AJCC v8" (3 trials), "Advanced Malignant Solid Neoplasm" (2 trials) and "Anatomic Stage II Breast Cancer AJCC v8" (2 trials). Many other conditions were trialed in "USC Norris Oncology/Hematology-Newport Beach" in a lesser frequency.

Most popular intervention types in "USC Norris Oncology/Hematology-Newport Beach" are "Drug" (47 trials), "Other" (36 trials), "Procedure" (27 trials), "Biological" (21 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (17 trials), "Biospecimen Collection" (16 trials), "Computed Tomography" (15 trials), "Quality-of-Life Assessment" (14 trials) and "Magnetic Resonance Imaging" (10 trials). Other intervention names were less common.

The vast majority of trials in "USC Norris Oncology/Hematology-Newport Beach" are 63 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "USC Norris Oncology/Hematology-Newport Beach". undefined are not yet recruiting, 23 are recruiting, 33 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in USC Norris Oncology/Hematology-Newport Beach, 2 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in USC Norris Oncology/Hematology-Newport Beach, 4 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".